Page 12 - மருந்து ப்ரைஸிஂக் ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New HHS Board Will Hear 340B Drug Pricing Disputes Tuesday, December 15, 2020 On December 14, 2020, HRSA established a long overdue Administrative Dispute Resolution (ADR) process that allows covered entities and drug manufacturers to bring claims against each other related to the 340B Drug Pricing Program (340B Program). The ADR process will allow covered entities and drug manufacturers to formally request agency review of alleged 340B violations. The ADR process will begin amid contentious disputes about the scope and future of the 340B Program. In recent months, multiple drug manufacturers have taken unilateral action to curtail the availability of 340B pricing dispensed through a covered entity’s contracted pharmacies. HRSA, the agency responsible for overseeing the 340B Program, has not yet issued a final opinion on those actions. Members of Congress have urged HRSA to take enforcement action against the manufacturers for violations of the Public Health Se

District of columbiaUnited statesHuman services officeHealth resourcesPublic health servicesMembers of congressNational association of community health centersUs district courtB programCenters for medicareOffice of pharmacy affairsServices administrationB drug pricing programMedicaid servicesAdministrative dispute resolutionDrug pricing program